StudyFinder
Monoclonal Gammopathy and Amyloidosis Registry and Biobank (MGARB)
Recruiting
The purpose of this study is to establish a registry and biobank to study monoclonal gammopathy and amyloidosis. We aim to understand better the changes these diseases cause, the symptoms they present, and the clinical progression to be able to better prevent them and treat them in the future.
Male or Female
18 years and over
Inclusion Criteria:
• diagnosis of monoclonal gammopathy or amyloidosis
Exclusion Criteria:
• unable to speak English
Rare Diseases
Clinics and Surgery Center (CSC), amyloidosis, monoclonal gammopathy
Krishna Allam - allam014@umn.edu
Sabine Karam
STUDY00018498